WHAT WE DO

IAG, Image Analysis Group is comprised of Image Analysis, Ltd. (London, UK), Image Analysis, Inc. (Philadelphia, PA, USA) and Venture Partners. IAG is a unique clinical development partner to life sciences companies, focused on accelerating drug development process and reducing the risk of failure through:

  • Optimized trial design and patient selection strategy (Strategy)
  • Efficient delivery of the imaging part of the trial (Trial Solutions)
  • Investment and commercialization of bio-pharma assets (Bio-Partnering)

IAG broadly leverages core image acquisition, management and image processing expertise. We believe that strategic use of imaging (MRI, CT, PET) accelerates drug development leading to lowers investment risks. We help biotech and pharma clients to choose optimal imaging modalities and identify the right methodologies to prove efficacy of their treatment.

We can work with prospective or retrospective data to find disease signatures and optimal patient selection criteria.

Our goal is to optimize trial outcomes and recruitment strategies saving our clients’ resources and budgets.

Our proprietary cloud platform DYNAMIKA ensures an efficient operational execution of the clinical programs. It supports seamless image logistics in a multi-center trial and provides central storage for all imaging data. The use of cloud allows for a real-time visibility over the trial progress and all stakeholders’ performance.

Our capabilities in algorithm development, AI, Machine Learning and Data Mining support our bio-pharma clients in making fast and objective decisions on the drug performance.

We help finding patient groups with best response rate and explain Mechanism of Action and treatment outcomes through imaging driven biomarkers.

IAG brings decades operational expertise, deep therapeutic insights, world-class expert team, risk-sharing business model and agile culture to accelerate novel drug development.

Our Bio-Partnering division and Venture Partners create successful partnerships that accelerate novel drug development and optimise financial and operational outcomes.

We are here to drive excellence for tomorrow’s innovative therapeutic agents.

OUR HISTORY BY OUR CEO

While studying for her PhD at Leeds, UK Olga Kubassova began work on commercialising her research. She was the first winner of the Sir Peter Thompson Enterprise Award, and ten years on her bright idea has developed into a global business with HQ in  London, UK and Philadelphia, USA. In this video, Olga talks about the encouragement she received in establishing the business, the fast growing team and endorsement from blue chip partners, which include top 10 pharmaceutical companies, innovative biotech and medtech players and IAG’s own portfolio companies.

STRATEGY

Targeted market assessment, patented benchmarking libraries, analytics platform and the most comprehensive expert advisory board  help our clients to formulate clear strategy and design the optimal trial for early go / no go decisions.

TRIAL SOLUTIONS

Integration of cloud platform, study-specific biomarkers with experience of IAG’ commercial and operational team ensures meeting your business objectives for growth or partnering, fast execution of projects and scientific credibility of the outcomes.

BIO-PARTNERING

An independent investment division of IAG seeks to partner with biotech companies with promising compounds at early stages of clinical development or academics with IP ready for commercialization.

Testimonials

Innovating together with promising life science companies and securing successful partnering arrangements has yielded spectacular results over the past 10 years. As a trusted partner to many biotech and pharma companies, IAG’s team is proud to share your words.

Publications

Since 2007, over 2000 articles were published by IAG’s team and advisory board to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.

Awards

From the Technology Innovation to the Entrepreneur of the Year, IAG’s team, its founder-CEO and its industry disrupting technology platform DYNAMIKA won 22 awards since 2007. We share, with pride and thanks!

Quality Management

ISO Quality Management System and SOPs audited by BSI and external partners as well as CE and FDA510K clearance for DYNAMIKA platform.

Events
We Are Hiring!

Do you want to join a fast-paced company using computer science, medical imaging and bold thinking to bring the best treatments to patients? We are hiring in Europe and USA giving you an international career, supportive team and ability to make real impact!